Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases

Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and (XIV) as muscarinic receptor 4(M4) antagonists for treating neurological diseases

US Patent 11033539 · Granted Jun 15, 2021

Estimated economic value: $93,607,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscarinic receptor 4 antagonists and methods of use2025
Muscarinic receptor 4 antagonists and methods of use2025
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors2023
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors2023
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquino2021
VMAT2 inhibitor compounds and compositions thereof2021
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-A]isoquino2018
N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them 2018
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido-[2,1-a]isoquino2017
N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them,2016
HIV replication inhibitors2015
N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions conta2015